Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.345 Q1 | 254 | 37 | 80 | 8836 | 1662 | 77 | 18.65 | 238.81 | |
2 | Pharmacology and Therapeutics | journal | 4.180 Q1 | 233 | 134 | 202 | 30111 | 2026 | 198 | 9.52 | 224.71 | |
3 | Natural Product Reports | journal | 2.753 Q1 | 211 | 53 | 128 | 9245 | 950 | 123 | 7.73 | 174.43 | |
4 | Annual Review of Pharmacology and Toxicology | journal | 9.892 Q1 | 224 | 17 | 77 | 2900 | 1854 | 77 | 25.96 | 170.59 | |
5 | Medicinal Research Reviews | journal | 2.620 Q1 | 150 | 24 | 83 | 4024 | 781 | 83 | 8.69 | 167.67 | |
6 | Reviews of Physiology Biochemistry and Pharmacology | journal | 6.223 Q1 | 70 | 8 | 44 | 1340 | 537 | 44 | 8.71 | 167.50 | |
7 | Current Cancer Drug Targets | journal | 2.656 Q1 | 103 | 44 | 141 | 7238 | 990 | 136 | 6.36 | 164.50 | |
8 | Progress in Medicinal Chemistry | journal | 0.849 Q2 | 38 | 8 | 23 | 1253 | 67 | 20 | 2.60 | 156.63 | |
9 | Critical Reviews in Toxicology | journal | 1.537 Q1 | 129 | 29 | 69 | 4381 | 317 | 63 | 3.80 | 151.07 | |
10 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.446 Q1 | 99 | 24 | 48 | 3594 | 210 | 45 | 4.00 | 149.75 | |
11 | CNS and Neurological Disorders - Drug Targets | journal | 1.820 Q1 | 96 | 55 | 146 | 8234 | 703 | 136 | 4.64 | 149.71 | |
12 | Current Enzyme Inhibition | journal | 19 | 29 | 0 | 4245 | 0 | 0 | 0.00 | 146.38 | ||
13 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.737 Q2 | 43 | 29 | 91 | 4161 | 232 | 91 | 2.42 | 143.48 | |
14 | Current Gene Therapy | journal | 1.267 Q1 | 80 | 46 | 138 | 6424 | 615 | 134 | 4.49 | 139.65 | |
15 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.719 Q1 | 82 | 13 | 36 | 1808 | 256 | 36 | 6.26 | 139.08 | |
16 | Current Medicinal Chemistry | journal | 1.847 Q1 | 202 | 249 | 597 | 33893 | 3484 | 562 | 5.59 | 136.12 | |
17 | Anti-Infective Agents | journal | 0.456 Q3 | 26 | 28 | 47 | 3662 | 80 | 43 | 1.70 | 130.79 | |
18 | Current Vascular Pharmacology | journal | 1.222 Q1 | 69 | 37 | 112 | 4751 | 422 | 109 | 4.05 | 128.41 | |
19 | Recent Patents on Anti-Cancer Drug Discovery | journal | 52 | 27 | 0 | 3398 | 0 | 0 | 0.00 | 125.85 | ||
20 | Current Neuropharmacology | journal | 0.515 Q3 | 103 | 28 | 55 | 3460 | 54 | 52 | 0.98 | 123.57 | |
21 | Drug Resistance Updates | journal | 2.412 Q1 | 132 | 19 | 92 | 2342 | 577 | 86 | 6.31 | 123.26 | |
22 | Recent Patents on CNS Drug Discovery | journal | 36 | 25 | 0 | 3055 | 0 | 0 | 0.00 | 122.20 | ||
23 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.818 Q2 | 45 | 25 | 112 | 3028 | 290 | 104 | 2.58 | 121.12 | |
24 | Current Drug Targets | journal | 1.512 Q1 | 119 | 161 | 224 | 19288 | 997 | 205 | 4.41 | 119.80 | |
25 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.240 Q3 | 17 | 39 | 0 | 4574 | 0 | 0 | 0.00 | 117.28 | |
26 | Current Drug Metabolism | journal | 1.835 Q1 | 122 | 65 | 123 | 7593 | 861 | 117 | 6.92 | 116.82 | |
27 | Current Pharmaceutical Design | journal | 1.801 Q1 | 183 | 390 | 915 | 45398 | 4967 | 805 | 5.58 | 116.41 | |
28 | Expert Opinion on Emerging Drugs | journal | 0.708 Q2 | 54 | 46 | 116 | 5338 | 331 | 116 | 3.06 | 116.04 | |
29 | Handbook of Experimental Pharmacology | journal | 0.446 Q1 | 110 | 181 | 153 | 20554 | 115 | 149 | 0.75 | 113.56 | |
30 | Infectious Disorders - Drug Targets | journal | 0.965 Q1 | 61 | 27 | 95 | 3047 | 276 | 88 | 2.68 | 112.85 | |
31 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.464 Q1 | 108 | 47 | 137 | 4962 | 589 | 131 | 4.18 | 105.57 | |
32 | Recent Patents on Cardiovascular Drug Discovery | journal | 30 | 27 | 0 | 2843 | 0 | 0 | 0.00 | 105.30 | ||
33 | Toxicological Reviews | journal | 0.695 Q2 | 49 | 20 | 75 | 2097 | 178 | 67 | 1.71 | 104.85 | |
34 | Current Computer-Aided Drug Design | journal | 32 | 28 | 0 | 2884 | 0 | 0 | 0.00 | 103.00 | ||
35 | Current Pharmaceutical Analysis | journal | 27 | 32 | 0 | 3266 | 0 | 0 | 0.00 | 102.06 | ||
36 | Current Topics in Medicinal Chemistry | journal | 1.554 Q1 | 133 | 151 | 369 | 15275 | 1773 | 328 | 4.28 | 101.16 | |
37 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.319 Q3 | 100 | 69 | 51 | 6961 | 76 | 51 | 1.49 | 100.88 | |
38 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 28 | 0 | 2804 | 0 | 0 | 0.00 | 100.14 | ||
39 | Advanced Drug Delivery Reviews | journal | 2.778 Q1 | 366 | 107 | 365 | 10459 | 3360 | 303 | 8.61 | 97.75 | |
40 | Cellular and Molecular Life Sciences | journal | 2.857 Q1 | 261 | 258 | 782 | 24555 | 4185 | 776 | 5.10 | 95.17 | |
41 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.225 Q3 | 27 | 40 | 101 | 3756 | 67 | 91 | 0.66 | 93.90 | |
42 | CNS Drug Reviews | journal | 1.246 Q1 | 64 | 19 | 72 | 1749 | 253 | 70 | 2.92 | 92.05 | |
43 | Neurotherapeutics | journal | 1.932 Q1 | 136 | 53 | 109 | 4821 | 655 | 98 | 6.01 | 90.96 | |
44 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 30 | 0 | 2647 | 0 | 0 | 0.00 | 88.23 | ||
45 | Inflammation and Allergy - Drug Targets | journal | 55 | 32 | 0 | 2799 | 0 | 0 | 0.00 | 87.47 | ||
46 | Current Pharmacogenomics | journal | 0.183 Q3 | 12 | 33 | 56 | 2875 | 34 | 56 | 0.61 | 87.12 | |
47 | Expert Opinion on Biological Therapy | journal | 0.910 Q2 | 102 | 118 | 426 | 10116 | 1358 | 420 | 3.26 | 85.73 | |
48 | Journal of NeuroImmune Pharmacology | journal | 91 | 40 | 0 | 3423 | 0 | 0 | 0.00 | 85.58 | ||
49 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | |
50 | Mini-Reviews in Medicinal Chemistry | journal | 0.975 Q1 | 107 | 141 | 272 | 11742 | 944 | 257 | 3.60 | 83.28 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®